Expand ATR Menu
ATR MENU

ATR Latest Press Releases

-- April 30, 2026 --

Aptar Reports First Quarter 2026 Results Business Wire 5:00 PM

-- April 27, 2026 --

Aptar Turns Beauty and Personal Care Products Upside Down with Inverted Lidless Dispensing Closures for Clean, Single-Handed Dispensing Business Wire 5:09 PM

-- April 23, 2026 --

Aptar Declares Quarterly Dividend Business Wire 5:00 PM

-- April 22, 2026 --

Aptar Recognized as One of America's Climate Leaders by USA Today for the Fourth Consecutive Year Business Wire 5:00 PM

-- April 8, 2026 --

Aptar Digital Health Partners with Enable Injections for enFuse Companion Digital Solution Globe Newswire 5:00 PM
Aptar Digital Health Partners with Enable Injections for enFuse Companion Digital Solution Business Wire 4:00 PM

-- March 19, 2026 --

Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA-051 Nasal Spray Business Wire 5:00 PM

-- March 17, 2026 --

Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year Business Wire 5:11 PM

-- March 16, 2026 --

Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN Nasal Spray Business Wire 5:00 PM

-- February 18, 2026 --

Aptar to Participate in Upcoming Investor Conferences Business Wire 5:00 PM

-- February 5, 2026 --

Aptar Reports Fourth Quarter and Annual 2025 Results Business Wire 5:00 PM

-- January 22, 2026 --

Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details Business Wire 5:00 PM

-- January 21, 2026 --

Aptar Again Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment Business Wire 5:00 PM

-- January 13, 2026 --

Aptar's Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate Business Wire 5:00 PM

-- January 12, 2026 --

Aptar's Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink Business Wire 5:00 PM

-- January 7, 2026 --

Aptar Announces 2026 Quarterly Conference Call Dates Business Wire 5:00 PM

-- January 6, 2026 --

Aptar Digital Health and OURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy with Oura Ring Business Wire 5:00 PM

-- January 5, 2026 --

Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Business Wire 5:13 PM

-- December 17, 2025 --

Aptar's Bidose Nasal System Delivers CARDAMYST (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) Business Wire 5:00 PM

-- December 4, 2025 --

Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year Business Wire 5:00 PM
Market Data Delayed 15 Minutes